When we started Bellus Medical in 2012, our goal was to create a company that was patient-focused, as well as product-focused. Today, we are an industry leader, a trusted provider, and soon we will be global!
We are excited to announce that Bellus Medical has completed the CE Mark registration for our SkinPen® Microneedling Cartridge, SkinPen® Precision Microneedling Pen and Skinfuse® Lift Hydrogel.
Specifically, this means we can now sell our SkinPen® microneedling system commercially to physicians within the European Union. Providing practices in Europe with a safe, reliable and effective device is an accomplishment for which we are extremely proud. We expect to launch into Europe before the end of 2017.
Combined with our ISO 13485:2016 Certification, this more broadly reinforces our commitment to providing the safest, highest-quality and most cutting-edge devices and products on the market. Receiving the CE Mark represents a significant milestone for Bellus Medical, and we are thrilled about the opportunity to expand this commitment beyond the U.S.
The aesthetics community has eagerly anticipated the expected quality improvements of devices in the microneedling category, and we look forward to the SkinPen® brand’s broad adoption in Europe.
NOTE: Today’s announcement is intended only for business conducted in Europe under CE Mark Registration No. 673398. For more information, read our press release here.